Breakthrough directed evolution system boosts virus-like particles for safer, more efficient gene editing, offering a powerful tool for next-generation therapeutic innovations. Study: Directed ...

The CDC's Advisory Committee on Immunization Practices (ACIP) unanimously recommended that U.S. travelers ages 12 years and older receive the virus-like particle chikungunya vaccine (Vimkunya) when ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Viral mimic systems and other tech platforms could enable local testing of vaccine candidates and antiviral therapies. This is important in the context of low resourced health settings, Africa’s focus ...

A more effective vaccine technology may be on the horizon. In a new study in mice, researchers from the University of Copenhagen demonstrate that a simple addition to mRNA vaccines can significantly ...

The new foot-and-mouth disease vaccine developed by researchers at Diamond Light Source is projected to deliver over $1.3 billion in annual benefits and transform global livestock resilience. Science ...

Vaccination remains the most effective strategy for avian influenza prevention and control in humans, despite varying vaccine efficacy across strains. Science X Daily and the Weekly Email Newsletter ...

This letter to the editor presents an in-depth overview of the current state of Nipah virus (NiV) vaccine development, highlighting both scientific advancements and critical challenges that still ...

The Chikungunya virus is spread by infected mosquitoes and causes symptoms like fever and severe joint pain. There is no specific medicine to treat the virus, and the best way to prevent it is by ...

The lack of high-resolution structures of the hantavirus glycoprotein tetramer and its lattice organization has limited mechanistic insights into viral assembly and entry. The authors leveraged a ...